648921-37-3 Usage
Uses
Used in Scientific Research:
3,3-DIMETHYL-PIPERIDIN-4-ONE HCL SALT is used as a research chemical for [application reason] in the field of scientific research. Its unique structure and properties make it a valuable compound for studying various chemical reactions and processes.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 3,3-DIMETHYL-PIPERIDIN-4-ONE HCL SALT is used as a key intermediate or building block for the synthesis of various drug molecules. Its presence in the molecular structure can contribute to the development of new medications with potential therapeutic applications.
Used in Chemical Synthesis:
3,3-DIMETHYL-PIPERIDIN-4-ONE HCL SALT is used as a reagent or catalyst in the synthesis of other complex organic compounds. Its versatility in chemical reactions allows for the creation of a wide range of products, from specialty chemicals to advanced materials.
Used in Analytical Chemistry:
3,3-DIMETHYL-PIPERIDIN-4-ONE HCL SALT is used as a reference material or standard in analytical chemistry for the calibration of instruments and the development of analytical methods. Its well-defined chemical properties make it suitable for these applications, ensuring accurate and reliable results in various analytical techniques.
Check Digit Verification of cas no
The CAS Registry Mumber 648921-37-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,8,9,2 and 1 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 648921-37:
(8*6)+(7*4)+(6*8)+(5*9)+(4*2)+(3*1)+(2*3)+(1*7)=193
193 % 10 = 3
So 648921-37-3 is a valid CAS Registry Number.
648921-37-3Relevant academic research and scientific papers
ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE
-
Paragraph 0530; 0533; 0534, (2017/12/31)
Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.
NOVEL SUBSTITUTED IMIDAZOPYRIDINE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN-2,3-DIOXYGENASE
-
Page/Page column 44, (2017/12/15)
Disclosed herein are substituted imidazopyridine compounds of formula (I) which are inhibitors of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan-2,3-dioxygenase (TDO) enzymes: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO- and/or TDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO- and/or TDO-associated disease or disorder.
ASYMMETRIC UREAS AND MEDICAL USES THEREOF
-
Page/Page column 45, (2012/09/10)
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I):
ASYMMETRIC UREAS AND MEDICAL USES THEREOF
-
Page/Page column 61, (2012/09/11)
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I).
